Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
We recently reported that mice deficient in the programmed cell death-1 (PD-1) immunoinhibitory coreceptor develop autoimmune dilated cardiomyopathy (DCM), with production of high-titer autoantibodies against a heart-specific, 30-kDa protein. In this study, we purified the 30-kDa protein from heart extract and identified it as cardiac troponin I (cTnI), encoded by a gene in which mutations can cause familial hypertrophic cardiomyopathy (HCM). Administration of monoclonal antibodies to cTnI induced dilatation and dysfunction of hearts in wild-type mice. Monoclonal antibodies to cTnI stained the surface of cardiomyocytes and augmented the voltage-dependent L-type Ca2+ current of normal cardiomyocytes. These findings suggest that antibodies to cTnI induce heart dysfunction and dilatation by chronic stimulation of Ca2+ influx in cardiomyocytes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the cardiotoxicity of anti-cTnI autoantibodies has been reported in studies using BALB/c mice lacking PD-1 expression”
From Autoimmune Myocarditis, Old Dogs and New Tricks. (2024) · cites this paper as [97]
In the citing paper
“PD-1-deficient BALB/c mice spontaneously developed autoimmune DCM mediated by anti-cTnI antibodies, and the pathology was transferable when wild-type mice were treated with these autoantibodies”
From Autoimmune Myocarditis, Old Dogs and New Tricks. (2024) · cites this paper as [97]
In the citing paper
“suggesting a potential mechanism of ICI myocarditis.”
From Autoimmune Myocarditis, Old Dogs and New Tricks. (2024) · cites this paper as [97]
In the citing paper
“the cardiotoxicity of anti-cTnI antibodies has been reported in PD-1 -/- BALB/c mice”
From Autoimmune Myocarditis, Old Dogs and New Tricks. (2024) · cites this paper as [97]
In the citing paper
“However, these autoantibodies are generally not disease-specific and may not consistently induce the disease phenotype in murine models, indicating their limitations as diagnostic and therapeutic targets. 57,92,97,191”
From Autoimmune Myocarditis, Old Dogs and New Tricks. (2024) · cites this paper as [97]
Citations
Cites
Hamill, O. P., Marty, A., Neher, E., Sakmann, B., & Sigworth, F. J. (1981) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/bf00656997 · Cited by 18,436
A Calcineurin-Dependent Transcriptional Pathway for Cardiac Hypertrophy
Molkentin, J. D., Lu, J.-R., Antos, C. L., Markham, B., Richardson, J., Robbins, J., Grant, S. R., & Olson, E. N. (1998) · Cell · doi:10.1016/s0092-8674(00)81573-1 · Cited by 2,566
Autoimmune Dilated Cardiomyopathy in PD-1 Receptor-Deficient Mice
Nishimura, H., Okazaki, T., Tanaka, Y., Nakatani, K., Hara, M., Matsumori, A., Sasayama, S., Mizoguchi, A., Hiai, H., Minato, N., et al. (2001) · Science · doi:10.1126/science.291.5502.319 · Cited by 1,868
Self-citationThe Genetic Basis for Cardiomyopathy
Seidman, J. G., & Seidman, C. (2001) · Cell · doi:10.1016/s0092-8674(01)00242-2 · Cited by 1,046
Calcium tolerant ventricular myocytes prepared by preincubation in a ?KB medium?
Isenberg, G., & Klockner, U. (1982) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/bf00584963 · Cited by 898
Mutations in Sarcomere Protein Genes as a Cause of Dilated Cardiomyopathy
Kamisago, M., Sharma, S. D., DePalma, S. R., Solomon, S., Sharma, P., McDonough, B., Smoot, L., Mullen, M. P., Woolf, P. K., Wigle, E. D., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012073432304 · Cited by 720
Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy
Kimura, A., Harada, H., Park, J.-E., Nishi, H., Satoh, M., Takahashi, M., Hiroi, S., Sasaoka, T., Ohbuchi, N., Nakamura, T., et al. (1997) · Nature Genetics · doi:10.1038/ng0897-379 · Cited by 577
Cardiac myosin induces myocarditis in genetically predisposed mice.
Neu, N., Rose, N. R., Beisel, K. W., Herskowitz, A., Gurri-Glass, G., & Craig, S. W. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.11.3630 · Cited by 526
Cardiac defects and altered ryanodine receptor function in mice lacking FKBP12
Shou, W., Aghdasi, B., Armstrong, D. L., Guo, Q., Bao, S., Charng, M.-J., Mathews, L. M., Schneider, M. D., Hamilton, S. L., & Matzuk, M. M. (1998) · Nature · doi:10.1038/35146 · Cited by 431
Cited by
Items 201–300 of 688
Pathological autoantibodies in cardiomyopathy
Jahns, R., Boivin, V., Schwarzbach, V., Ertl, G., & Lohse, M. J. (2008) · Autoimmunity · doi:10.1080/08916930802031603 · Cited by 65
Regulation of Trypanosoma cruzi-Induced Myocarditis by Programmed Death Cell Receptor 1
Gutierrez, F. R. S., Mariano, F. S., Oliveira, C. J. F., Pavanelli, W. R., Guedes, P. M. D. M., Silva, G. K., Campanelli, A. P., Milanezi, C. M., Azuma, M., Honjo, T., et al. (2011) · Infection and Immunity · doi:10.1128/iai.01047-10 · Cited by 64
Self-citationAutoimmunological features in inflammatory cardiomyopathy
Kallwellis-Opara, A., Dörner, A., Poller, W. C., Noutsias, M., Kühl, U., Schultheiß, H., & Pauschinger, M. (2007) · Clinical Research in Cardiology · doi:10.1007/s00392-007-0524-x · Cited by 63
Control of foreign Ag‐specific Ab responses by Treg and Tfr
Wing, J. B., Lim, E. L., & Sakaguchi, S. (2020) · Immunological Reviews · doi:10.1111/imr.12888 · Cited by 59
Role of β1-adrenoceptor autoantibodies in the pathogenesis of dilated cardiomyopathy
Dandel, M., Wallukat, G., Potapov, E. V., & Hetzer, R. (2011) · Immunobiology · doi:10.1016/j.imbio.2011.07.012 · Cited by 57
Kijima, T., Hazama, S., Tsunedomi, R., Tanaka, H., Takenouchi, H., Kanekiyo, S., Inoue, Y., Nakashima, M., Iida, M., Sakamoto, K., et al. (2016) · Oncology Reports · doi:10.3892/or.2016.5267 · Cited by 57
A Century of Radiation Therapy and Adaptive Immunity
Schaue, D. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00431 · Cited by 59
Aso, M., Toi, Y., Sugisaka, J., Aiba, T., Kawana, S., Saito, R., Ogasawara, T., Tsurumi, K., Ono, K., Shimizu, H., et al. (2019) · The Oncologist · doi:10.1634/theoncologist.2019-0550 · Cited by 58
PD-1/PDL-1 Inhibitors and Cardiotoxicity; Molecular, Etiological and Management Outlines
Safi, M., Ahmed, H., Al‐Azab, M., Xia, Y., Shan, X., Alradhi, M., Al-Danakh, A., Shopit, A., & Liu, J. (2020) · Journal of Advanced Research · doi:10.1016/j.jare.2020.09.006 · Cited by 61
Cheng, A., Zhang, Y., Blasco‐Colmenares, E., Dalal, D., Butcher, B., Norgard, S., ELDADAH, Z. A., Ellenbogen, K. A., Dickfeld, T. M., SPRAGG, D. D., et al. (2014) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.113.001705 · Cited by 56
Arangalage, D., Degrauwe, N., Michielin, O. A., Monney, P. A., & Özdemir, B. C. (2021) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2021.102282 · Cited by 56
Immune checkpoint inhibitors associated cardiovascular immune-related adverse events
Jo, W., Won, T., Daoud, A., & Čiháková, D. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1340373 · Cited by 55
Programmed Death-1 Gene Polymorphisms in Patients With Systemic Lupus Erythematosus in Taiwan
Wang, S., Chen, Y., Ou, T., Wu, C., Tsai, W., Liu, H., & Yen, J. (2006) · Journal of Clinical Immunology · doi:10.1007/s10875-006-9048-9 · Cited by 59
Recent Insights Into the Role of Autoimmunity in Idiopathic Dilated Cardiomyopathy
Lappé, J. M., Pelfrey, C. M., & Tang, W. H. W. (2008) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2008.02.016 · Cited by 59
B cells in human and murine systemic lupus erythematosus
Anolik, J. H., & Sanz, I. (2004) · Current Opinion in Rheumatology · doi:10.1097/01.bor.0000133660.52599.f6 · Cited by 55
Caforio, A. L. P., Angelini, A., Blank, M., Shani, A., Kivity, S., Goddard, G., Doria, A., Schiavo, A., Testolina, M., Bottaro, S., et al. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.10.165 · Cited by 53
Molecular fingerprints of cardiovascular toxicities of immune checkpoint inhibitors
Gergely, T. G., Drobni, Z. D., Sayour, N. V., Ferdinandy, P., & Varga, Z. V. (2024) · Basic Research in Cardiology · doi:10.1007/s00395-024-01068-8 · Cited by 55
The genetic basis of systemic lupus erythematosus--knowledge of today and thoughts for tomorrow
Prokunina‐Olsson, L., & Alarcon-Riquelme, M. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh076 · Cited by 60
Immune checkpoints in cardiac physiology and pathology: therapeutic targets for heart failure
Gergely, T. G., Drobni, Z. D., Kallikourdis, M., Zhu, H., Meijers, W. C., Neilan, T. G., Rassaf, T., Ferdinandy, P., & Varga, Z. V. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-023-00986-9 · Cited by 63
Autoimmune Myocarditis, Old Dogs and New Tricks.
Won, T., Song, E. J., Kalinoski, H. M., Moslehi, J. J., & Čiháková, D. (2024) · Circulation Research · doi:10.1161/circresaha.124.323816 · Cited by 51
Pathophysiology of Immune Checkpoint Inhibitor-Induced Myocarditis
Jiménez-Alejandre, R., Ruiz‐Fernández, I., & Martín, P. (2022) · Cancers · doi:10.3390/cancers14184494 · Cited by 50
Immunoadsorption in dilated cardiomyopathy: long‐term reduction of cardiodepressant antibodies
Trimpert, C., Herda, L. R., Eckerle, L. G., Pohle, S., Müller, C., Landsberger, M., Felix, S. B., & Staudt, A. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02314.x · Cited by 51
PD-1/PD-L1, PD-1/PD-L2, and other co-inhibitory signaling pathways in transplantation
del Rio, M., Bühler, L. H., Gibbons, C., Tian, J., & Rodríguez-Barbosa, J.-I. (2008) · Transplant International · doi:10.1111/j.1432-2277.2008.00726.x · Cited by 57
Anti-breast cancer-induced cardiomyopathy: Mechanisms and future directions
Liu, C., Chen, H., Guo, S., Liu, Q., Chen, Z., Huang, H., Zhao, Q., Li, L., Cen, H., Jiang, Z., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115373 · Cited by 26
PD-1 blockage delays murine squamous cell carcinoma development
Belai, E. B., de Oliveira, C. E., Gasparoto, T. H., Ramos, R. N., Torres, S. A., Garlet, G. P., Cavassani, K. A., Silva, J. S., & Campanelli, A. P. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt305 · Cited by 52
Cardiotoxicities associated with immune checkpoint inhibitors
Yang, S., & Asnani, A. H. (2018) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2018.07.002 · Cited by 50
Immunobiology of Cancer Therapies Targeting CD137 and B7-H1/PD-1 Cosignal Pathways
Wang, S., & Chen, L. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_81 · Cited by 53
Hayward, S. L., Bautista-Lopez, N., Suzuki, K., Atrazhev, A. M., Dickie, P., & Elliott, J. F. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.12.7715 · Cited by 49
Autoimmune heart failure: new understandings of pathogenesis
Eriksson, U., & Penninger, J. M. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.06.014 · Cited by 53
Anti-troponin autoantibodies and the cardiovascular system
Nussinovitch, U., & Shoenfeld, Y. (2010) · Heart · doi:10.1136/hrt.2010.195255 · Cited by 50
Beta 1-adrenergic receptor-directed autoimmunity as a cause of dilated cardiomyopathy in rats
Jahns, R., Boivin, V., & Lohse, M. J. (2006) · International Journal of Cardiology · doi:10.1016/j.ijcard.2006.05.008 · Cited by 55
Rubio‐Infante, N., Ramírez‐Flores, Y. A., Castillo, E. C., Lozano, O., García‐Rivas, G., & Torre‐Amione, G. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.851032 · Cited by 50
Autoimmunity against a Tissue Kallikrein in IQI/Jic Mice
Takada, K., Takiguchi, M., Konno, A., & Inaba, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m410157200 · Cited by 48
van den Hoogen, P., de Jager, S. C. A., Huibers, M. M. H., Schoneveld, A. H., Puspitasari, Y. M., Valstar, G., Oerlemans, M. I. F. J., de Weger, R. A., Doevendans, P. A., den Ruijter, H. M., et al. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14619 · Cited by 51
Immune checkpoint inhibitors in osteosarcoma: A hopeful and challenging future
Zhang, Z., Tan, X., Jiang, Z., Wang, H., & Yuan, H. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1031527 · Cited by 54
Soluble PD-1 is Associated with Aberrant Regulation of T Cells Activation in Aplastic Anemia
Wu, H., Miao, M., Zhang, G., Hu, Y., Ming, Z., & Zhang, X. (2009) · Immunological Investigations · doi:10.1080/08820130902912332 · Cited by 48
Immune-Related Adverse Events: A Case-Based Approach
Connolly, C. M., Bambhania, K., & Naidoo, J. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00530 · Cited by 47
Okazaki, T., Otaka, Y., Wang, J., Hiai, H., Takai, T., Ravetch, J. V., & Honjo, T. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051984 · Cited by 50
Self-citationImpact of troponin I-autoantibodies in chronic dilated and ischemic cardiomyopathy
Doesch, A. O., Mueller, S., Nelles, M., Konstandin, M. H., Celik, S., Frankenstein, L., Göser, S., Kaya, Z., Koch, A., Zugck, C., et al. (2010) · Basic Research in Cardiology · doi:10.1007/s00395-010-0126-z · Cited by 51
Coinhibitory Molecules in Autoimmune Diseases
Watanabe, N., & Nakajima, H. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/269756 · Cited by 45
Lethal immunoglobulins: Autoantibodies and sudden cardiac death
Ryabkova, V. A., Shubik, Y. V., Владимирович, Э. М., Churilov, L. P., Kanduc, D., & Shoenfeld, Y. (2019) · Autoimmunity Reviews · doi:10.1016/j.autrev.2018.12.005 · Cited by 46
Regulation of PD-1 in T cells for cancer immunotherapy
Yu, X., Gao, R., Li, Y., & Zeng, C. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173240 · Cited by 52
Regulatory T Cells Induced by Mucosal B Cells Alleviate Allergic Airway Hypersensitivity
Chu, K., & Chiang, B. (2011) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2011-0246oc · Cited by 45
Cardiotoxicity of Cancer Treatments: Focus on Anthracycline Cardiomyopathy
Nishi, M., Wang, P., & Hwang, P. M. (2021) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.121.316697 · Cited by 53
Anti-heart autoantibodies in familial dilated cardiomyopathy
Caforio, A. L. P., Vinci, A., & Iliceto, S. (2008) · Autoimmunity · doi:10.1080/08916930802031546 · Cited by 49
Pathogenic roles of cardiac autoantibodies in dilated cardiomyopathy
Okazaki, T., & Honjo, T. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2005.05.001 · Cited by 47
Self-citationMolecular Characterization of Virus-induced Autoantibody Responses
Ludewig, B., Krebs, P., Metters, H., Tatzel, J., Türeci, Ö., & Şahin, U. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040358 · Cited by 44
Genetics of cancer therapy-associated cardiotoxicity
Kim, Y., Seidman, J. G., & Seidman, C. E. (2022) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2022.03.010 · Cited by 48
Baba, A., Akaishi, M., Shimada, M., Monkawa, T., Wakabayashi, Y., Takahashi, M., Nagatomo, Y., & Yoshikawa, T. (2010) · Circulation Journal · doi:10.1253/circj.cj-09-0748 · Cited by 43
Staudt, A., Herda, L. R., Trimpert, C., Lubenow, L., Landsberger, M., Dörr, M., Hummel, A., Eckerle, L. G., Beug, D., Müller, C. R., et al. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.246 · Cited by 46
Cardiomyopathy — An approach to the autoimmune background
Becker, N., Müller, J., Göttel, P., Wallukat, G., & Schimke, I. (2017) · Autoimmunity Reviews · doi:10.1016/j.autrev.2017.01.012 · Cited by 45
Baldini, E., Lunghi, A., Cortesi, E., Turci, D., Signorelli, D., Stati, V., Melotti, B., Ricciuti, B., Frassoldati, A., Romano, G., et al. (2019) · Lung Cancer · doi:10.1016/j.lungcan.2019.12.014 · Cited by 46
Baik, A. H., Tsai, K. K., Oh, D. Y., & Aras, M. A. (2021) · Clinical Science · doi:10.1042/cs20200331 · Cited by 44
Liu, L., Zheng, Q., Lee, J. H., Ma, Z., Zhu, Q., & Wang, Z. (2015) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12467 · Cited by 43
The PD-1 pathway as a therapeutic target to overcome immune escape mechanisms in cancer
Henick, B. S., Herbst, R. S., & Goldberg, S. B. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.955794 · Cited by 43
Blocking immune checkpoints in prostate, kidney, and urothelial cancer: An overview
Alme, A., Karir, B. S., Faltas, B. M., & Drake, C. G. (2016) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2016.01.006 · Cited by 45
Immunoadsorption therapy in dilated cardiomyopathy
Felix, S. B., Beug, D., & Dörr, M. (2014) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2015.990385 · Cited by 42
Canale, M. L., Camerini, A., Casolo, G., Lilli, A., Bisceglia, I., Parrini, I., Lestuzzi, C., Meglio, J. D., PUCCETTI, C., Camerini, L., et al. (2020) · Advances in Therapy · doi:10.1007/s12325-020-01386-y · Cited by 42
Han, P., Yu, T., Hou, Y., Zhao, Y., Liu, Y., Sun, Y., Wang, H., Xu, P., Li, G., Sun, T., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.630693 · Cited by 41
Pseudoprogression in lung cancer patients treated with immunotherapy
Chen, M., & Zeng, Y. (2021) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2021.103531 · Cited by 42
Miettinen, K. H., Eriksson, S., Magga, J., Tuomainen, P. O., Kuusisto, J., Vanninen, E. J., Turpeinen, A., Punnonen, K. R. A., Pettersson, K. S. I., & PEUHKURINEN, K. J. (2008) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2008.02.009 · Cited by 44
Staudt, A., Staudt, Y., Hummel, A., Empen, K., Dörr, M., Trimpert, C., Birkenmeier, K., Kühl, U., Noutsias, M., Russ, D., et al. (2006) · Therapeutic Apheresis and Dialysis · doi:10.1111/j.1744-9987.2006.00343.x · Cited by 44
Dilated cardiomyopathy update: infectious-immune theory revisited
Kawai, C., & Matsumori, A. (2013) · Heart Failure Reviews · doi:10.1007/s10741-013-9401-z · Cited by 40
Self-citationImmune checkpoint inhibitors in the onset of myasthenia gravis with hyper CK emia
Takamatsu, K., Nakane, S., Suzuki, S., Kosaka, T., Fukushima, S., Kimura, T., Miyashita, A., Mukaino, A., Yamakawa, S., Watanabe, K., et al. (2018) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.654 · Cited by 41
Khaddour, K., Singh, V., & Shayuk, M. (2019) · BMC Cancer · doi:10.1186/s12885-019-5661-x · Cited by 39
The Role of B Cells in Cardiomyopathy and Heart Failure
Bermea, K. C., Bhalodia, A., Huff, A., Rousseau, S. T., & Adamo, L. (2022) · Current Cardiology Reports · doi:10.1007/s11886-022-01722-4 · Cited by 43
Prevalence of Autoantibodies to Cardiac Troponin T in Healthy Blood Donors
Adamczyk, M., Brashear, R. J., & Mattingly, P. G. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2009.125781 · Cited by 39
Anti-cardiac troponin antibodies in clinical human disease: a systematic review
Vilela, E., Bettencourt‐Silva, R., da Costa, J. T., Barbosa, A. R., Silva, M. P., Teixeira, M., Primo, J. J., Ribeiro, V. G., & Nunes, J. P. L. (2017) · Annals of Translational Medicine · doi:10.21037/atm.2017.07.40 · Cited by 38
Wang, F., Sun, X., Qin, S., Hua, H., Liu, X., Yang, L., & Yang, M. (2020) · Chinese Clinical Oncology · doi:10.21037/cco.2020.03.08 · Cited by 41
Cardiotoxicity risk factors with immune checkpoint inhibitors
Brumberger, Z. L., Branch, M. E., Klein, M. W., Seals, A. L., Shapiro, M. D., & Vasu, S. (2022) · Cardio-Oncology · doi:10.1186/s40959-022-00130-5 · Cited by 48
Cardiac Troponin I (cTnI) concentration in an ovine model of myocardial ischemia
Leonardi, F., Passeri, B., Fusari, A., Razza, P. D., Beghi, C., Lorusso, R., Corradi, A., & Botti, P. (2007) · Research in Veterinary Science · doi:10.1016/j.rvsc.2007.09.010 · Cited by 38
Cao, D., Xu, H., Guo, G., Ruan, Z., Fei, L., Xie, Z., Wu, Y., & Chen, Y. (2012) · Inflammation · doi:10.1007/s10753-012-9525-7 · Cited by 39
Ferreira, M., Pichon, É., Carmier, D., Bouquet, É., Pageot, C., Bejan‐Angoulvant, T., Campana, M., Vermès, E., & Marchand-Adam, S. (2018) · Targeted Oncology · doi:10.1007/s11523-018-0579-9 · Cited by 37
Genetically determined myocarditis: clinical presentation and immunological characteristics
Caforio, A. L. P., & Iliceto, S. (2008) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e3282fbf572 · Cited by 39
Mouse Models of Autoimmune Diseases - Autoimmune Myocarditis
Muller, A.-M., Fischer, A., Katus, H., & Kaya, Z. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666150316123711 · Cited by 35
Site-Specific Radiolabeling of a Human PD-L1 Nanobody via Maleimide–Cysteine Chemistry
Chigoho, D. M., Lecocq, Q., Awad, R. M., Breckpot, K., Devoogdt, N., Keyaerts, M., Caveliers, V., Xavier, C., & Bridoux, J. (2021) · Pharmaceuticals · doi:10.3390/ph14060550 · Cited by 36
Immune Checkpoint Inhibitor Associated Myocarditis and Cardiomyopathy: A Translational Review
Wang, D., Bauersachs, J. K., & Berliner, D. (2023) · Biology · doi:10.3390/biology12030472 · Cited by 41
Cardiac phenotype in mouse models of systemic autoimmunity
Sanghera, C., Wong, L. M., Panahi, M., Sintou, A., Hasham, M. G., & Sattler, S. (2019) · Disease Models & Mechanisms · doi:10.1242/dmm.036947 · Cited by 38
Anti-troponin antibodies following myocardial infarction
O’Donohoe, T. J., Ketheesan, N., & Schrale, R. G. (2016) · Journal of Cardiology · doi:10.1016/j.jjcc.2016.07.018 · Cited by 65
Ameling, S., Bhardwaj, G., Hammer, E., Beug, D., Steil, L., Reinke, Y., Weitmann, K., Grube, M., Trimpert, C., Klingel, K., et al. (2016) · Basic Research in Cardiology · doi:10.1007/s00395-016-0569-y · Cited by 42
Huang, R., Shen, Z.-Y., Huang, D., Zhao, S.-H., Dan, L.-X., Wu, P., Tang, Q., & Ma, Z. (2025) · Nature Communications · doi:10.1038/s41467-025-58107-8 · Cited by 39
Control of inflammatory heart disease by CD4+ T cells
Barin, J. G., & Čiháková, D. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12134 · Cited by 34
Yoshikawa, T., Baba, A., Akaishi, M., Wakabayashi, Y., Monkawa, T., Kitakaze, M., Izumi, T., & Tomoike, H. (2016) · Journal of Clinical Apheresis · doi:10.1002/jca.21446 · Cited by 33
Huertas, R. M., Saavedra, C., Perna, C., Gómez, A. F., & Gordoa, T. A. (2019) · Cancer Management and Research · doi:10.2147/cmar.s185202 · Cited by 35
Role of the Immune System Elements in Pulmonary Arterial Hypertension
Tomaszewski, M., Bębnowska, D., Hrynkiewicz, R., Dworzyński, J., Niedźwiedzka‐Rystwej, P., Kopeć, G., & Grywalska, E. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10163757 · Cited by 36
The role of immune checkpoints in cardiovascular disease
Yousif, L. I. E., Tanja, A. A. N., de Boer, R. A., Teske, A. J., & Meijers, W. C. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.989431 · Cited by 35
Landsberger, M., Staudt, A., Choudhury, S., Trimpert, C., Herda, L. R., Klingel, K., Kandolf, R., Schultheiß, H., Kroemer, H. K., Völker, U., et al. (2008) · American Heart Journal · doi:10.1016/j.ahj.2008.02.015 · Cited by 38
Antibody-Based Therapy in Colorectal Cancer
Noguchi, T., Ritter, G., & Nishikawa, H. (2013) · Immunotherapy · doi:10.2217/imt.13.35 · Cited by 34
Frenkel, D., Pachori, A. S., Zhang, L., Dembinsky‐Vaknin, A., Farfara, D., Petrovic-Stojkovic, S., Dzau, V. J., & Weiner, H. L. (2009) · International Immunology · doi:10.1093/intimm/dxp051 · Cited by 33
Biomarkers and risk factors for the early prediction of immune-related adverse events: a review
Zhang, Y., Zhang, X., Li, W., Du, Y., Hu, W., & Zhao, J. (2022) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2021.2018894 · Cited by 34
Immunoadsorption as treatment option in dilated cardiomyopathy
Felix, S. B., & Staudt, A. (2008) · Autoimmunity · doi:10.1080/08916930802031173 · Cited by 33
Felix, S. B., & Staudt, A. (2006) · International Journal of Cardiology · doi:10.1016/j.ijcard.2006.05.014 · Cited by 34
Functional Tolerance of CD8+ T Cells Induced by Muscle-Specific Antigen Expression
Calbo, S., Delagreverie, H. M., Arnoult, C., Authier, F., Tron, F., & Boyer, O. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.1.408 · Cited by 32
Chiang, C., Song, J., Chi, K., Chang, Y.-C., Xanthavanij, N., Chang, Y., Hsia, Y. P., Chiang, C.-H., Ghamari, A., Reynolds, K. L., et al. (2024) · European Journal of Cancer · doi:10.1016/j.ejca.2024.115170 · Cited by 34
Oya, Y., Watanabe, N., Kobayashi, Y., Owada, T., Oki, M., Ikeda, K., Suto, A., Kagami, S., Hirose, K., Kishimoto, T., et al. (2011) · International Immunology · doi:10.1093/intimm/dxr017 · Cited by 33
Zito, C., Manganaro, R., Ciappina, G., Spagnolo, C. C., Racanelli, V., Santarpía, M., Silvestris, N., & Carerj, S. (2022) · Cancers · doi:10.3390/cancers14215403 · Cited by 32
Fractalkine Signalling (CX3CL1/CX3CR1 Axis) as an Emerging Target in Coronary Artery Disease
Loh, S. X., Ekinci, Y., Spray, L., Jeyalan, V., Olin, T., Richardson, G. D., Austin, D., Alkhalil, M., & Spyridopoulos, I. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12144821 · Cited by 33
Dilated cardiomyopathy: learning to live with yourself
MacLellan, W. R., & Lusis, A. J. (2003) · Nature Medicine · doi:10.1038/nm1203-1455 · Cited by 32
Xu, L., Chen, Y., Xiong, L., Shen, Y., Zhou, Z., Wang, S., & Xu, X. (2025) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2025.2512645 · Cited by 36
Chruscinski, A. J., Huang, F. Y. Y., Nguyen, A. P., Lioe, J., Tumiati, L. C., Kozuszko, S., Tinckam, K. J., Rao, V. A., Dunn, S. E., Persinger, M. A., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151224 · Cited by 30
Metadata
- Authors
- Okazaki, T., Tanaka, Y., Nishio, R., Mitsuiye, T., Mizoguchi, A., Wang, J., Ishida, M., Hiai, H., Matsumori, A., Minato, N., & Honjo, T.
- Affiliations
- Kyoto University (JP)
- Mie University (JP)
- Corresponding author
- Honjo, Tasuku
- ORCID
- Venue
- Nature Medicine
- Published
- 2003-11-02
- Volume
- 9
- Issue
- 12
- Pages
- 1477-1483
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2140419562
- Semantic Scholar
- 8b8bf12ad1a303d244e325c58410b356c4ed2945
- Cited by
- 689
- References
- 38
- Citations by year
- 2026: 24 · 2025: 30 · 2024: 44 · 2023: 36 · 2022: 49 · 2021: 49 · 2020: 47 · 2019: 46 · 2018: 28 · 2017: 30 · 2016: 32 · 2015: 19 · 2014: 20 · 2013: 22 · 2012: 16
- FWCI
- 16.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Keywords
- cardiac troponin I, autoantibodies, dilated cardiomyopathy, PD-1 deficiency, autoimmune cardiomyopathy, familial hypertrophic cardiomyopathy, L-type calcium current, cardiac dysfunction, monoclonal antibodies
- MeSH terms
- Animals, Antibodies, Monoclonal, Antigens, Surface, Autoantibodies, Base Sequence, Cardiomyopathy, Dilated, Humans, Mice, Inbred A, Mice, Inbred BALB C, Mice, Nude, Antigens, CD, Rats, Wistar, DNA, Complementary, Mice, Knockout, Troponin I, Calcium Signaling, Myocytes, Cardiac, Apoptosis Regulatory Proteins, Mice, Rats, Programmed Cell Death 1 Receptor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.